Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-25T06:16:56.471Z Has data issue: false hasContentIssue false

Foreword — Global Access to Health: Legal, Business, and Policy Obstacles

Published online by Cambridge University Press:  06 January 2021

Erik Iverson
Affiliation:
Bill & Melinda Gates Foundation
Regina Rabinovich
Affiliation:
Infectious Diseases, Global Health Program, Bill & Melinda Gates Foundation
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Foreword
Copyright
Copyright © American Society of Law, Medicine and Ethics and Boston University 2008

References

1 Jeffrey H. Matsura, Thomas Jefferson and the Evolution of a Populist Vision of Intellectual Property Rights and Democratic Values, http://www.archipelago.org/vol10-34/matsuura.htm.

2 Thomas Jefferson, The Papers of Thomas Jefferson 1 January 1794 to 29 February 1796 (Princeton University Press 2000).

3 World Health Organization, The World Health Report 1998, Chapter 8, http://www.who.int/entity/whr/1998/en/whr98_ch8.pdf.

4 Jamison, Dean T., et al., Accomplishments, Challenges, and Priorities, Priorities in Health, 1, 122 (Oxford University Press 2006)CrossRefGoogle Scholar.

5 World Health Organization, e (revised January 2007), http://www.who.int/mediacentre/factsheets/fs286/en/index.html.

6 World Health Organization, Global Immunization Data (January 2008), http://www.who.int/immunization/newsroom/Global_Immunization_Data.pdf.

7 Jamison, Dean T., et al., The Way Forward: A Blueprint for Action, Priorities in Health 179-82 (Oxford University Press 2006)Google Scholar.

9 U.S. Census Bureau, 2006 estimates, http://www.census.gov.

10 Planning Report 07-1, Economic Analysis of the Technology Infrastructure Needs of the U.S. Biopharmaceutical Industry, RTI International, Nov. 2007 (prepared for National Institute of Standards & Technology) (biopharma firms spend some $21 billion a year on research and development).

11 Global Framework on Essential Health R&D, 367 The Lancet 1560 (2006). Although there are many ways of defining “Developing Countries,” the World Bank's categorization of “low-income economies” or “lower middle-income economies” are often referenced. Depending on the context and the parties offering a definition, such term might also include certain markets or countries within the categorization of “upper middle-income economies.”

12 Medicines for Malaria Venture, http://www.mmv.org ; TB Alliance, http://www.tballiance.org.

13 The Aeras Global TB Vaccine Foundation, http://www.aeras.org.

14 See The GAVI Alliance, http://www.gavialliance.org , for GAVI, IFFm, and ADIPs; see The Center for Global Development, Making Markets for Vaccines, http://www.cgdev.org/section/initiatives/_active/vaccinedevelopment , for AMCs.

15 Jefferson, Thomas: A Chronology of His Thoughts (Holmes, Jerry, ed. 2002)Google Scholar.